Lansen Pharmaceutical Holdings Ltd
HKEX:503
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lansen Pharmaceutical Holdings Ltd
HKEX:503
|
CN |
|
D
|
Delta Israel Brands Ltd
TASE:DLTI
|
IL |
|
R
|
Ronn
OTC:RONN
|
US |
|
O
|
Open Door Inc
OTC:OPNDF
|
JP |
|
Bullet Blockchain Inc
OTC:BULT
|
US |
Lansen Pharmaceutical Holdings Ltd
Lansen Pharmaceutical Holdings Ltd. engages in the development, manufacture, and distribution of pharmaceuticals products. The company is headquartered in Ningbo, Zhejiang and currently employs 591 full-time employees. The company went IPO on 2010-05-07. The firm operates through three segments. Specialty Pharmaceuticals segment is engaged in the development, production and sales of specialty pharmaceuticals mainly used in the fields of rheumatology and dermatology. Its main specialty pharmaceutical products include pafulin, leflunomide tablets and mycophenolate mofetil dispersible tablets. Plant Extract and Healthcare Products segment is engaged in the development, production and sales of Chinese medicine extracts and healthcare products. Other Pharmaceuticals segment is engaged in businesses related to other pharmaceuticals.
Lansen Pharmaceutical Holdings Ltd. engages in the development, manufacture, and distribution of pharmaceuticals products. The company is headquartered in Ningbo, Zhejiang and currently employs 591 full-time employees. The company went IPO on 2010-05-07. The firm operates through three segments. Specialty Pharmaceuticals segment is engaged in the development, production and sales of specialty pharmaceuticals mainly used in the fields of rheumatology and dermatology. Its main specialty pharmaceutical products include pafulin, leflunomide tablets and mycophenolate mofetil dispersible tablets. Plant Extract and Healthcare Products segment is engaged in the development, production and sales of Chinese medicine extracts and healthcare products. Other Pharmaceuticals segment is engaged in businesses related to other pharmaceuticals.
